Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias.

[1]  Benson S. Ku,et al.  HEART FAILURE POST-DISCHARGE TELEMONITORING IN A SAFETY-NET HOSPITAL REDUCES 30-DAY READMISSIONS , 2020 .

[2]  S. Rizzo,et al.  Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. , 2020, Journal of the American College of Cardiology.

[3]  L. Cooper.  Ventricular Arrhythmias and Sudden Cardiac Death in Lymphocytic Myocarditis. , 2020, Journal of the American College of Cardiology.

[4]  S. Iliceto,et al.  Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation.

[5]  C. Basso,et al.  Programmed ventricular stimulation in patients with active vs previous arrhythmic myocarditis , 2020, Journal of cardiovascular electrophysiology.

[6]  L. Cooper,et al.  Management of Myocarditis-Related Cardiomyopathy in Adults. , 2019, Circulation research.

[7]  S. Rizzo,et al.  Arrhythmias in myocarditis: State of the art. , 2019, Heart rhythm.

[8]  S. Rizzo,et al.  Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis. , 2019, International journal of cardiology.

[9]  S. Rizzo,et al.  Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study. , 2019, Journal of autoimmunity.

[10]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[11]  Michael J Ackerman,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.

[12]  A. Tomelleri,et al.  Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series. , 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  J. Healey,et al.  An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis , 2018, European heart journal.

[14]  William J. Bryant,et al.  2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.

[15]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[16]  Sabino Iliceto,et al.  Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes , 2016, Circulation. Arrhythmia and electrophysiology.

[17]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[18]  D. Tsiachris,et al.  Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[20]  A. Angelini,et al.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis , 2010, Heart.

[21]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[22]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[23]  A. Angelini,et al.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.

[24]  P. Elliott,et al.  Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives , 2006, Circulation.

[25]  G. Thiene,et al.  Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders , 2003, Circulation.

[26]  Romuald Wojnicz,et al.  Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results , 2001, Circulation.

[27]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[28]  B Lown,et al.  Approaches to Sudden Death from Coronary Heart Disease , 1971, Circulation.